Market Analysis and Insights: Global Lung Cancer Liquid Biopsy Market
Due to the pandemic of COVID-19, the global Lung Cancer Liquid Biopsy Market size is estimated to be worth US$ million in 2022 and is expected to reach the size of US$ million by 2028 growing at a CAGR of % during the forecast period. Fully considering the economic change by this health crisis, Exosomes and RNA accounted for % of the global Lung Cancer Liquid Biopsy Market in 2021 and is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to a % CAGR throughout this forecast period.
North America held a significant share of the global Lung Cancer Liquid Biopsy Market market in 2021 and was valued at US$ million in 2021. It is estimated to grow with a CAGR of % during the forecast period of 2022-2028 and is estimated to reach US$ million by 2028.
China Lung Cancer Liquid Biopsy Market size is valued at US$ million in 2021, while the US and Europe Lung Cancer Liquid Biopsy Market are US$ million and US$ million, respectively. The share of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China’s share will reach % in 2028, trailing a CAGR of % through the forecast period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Lung Cancer Liquid Biopsy Market landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Lung Cancer Liquid Biopsy Market include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics, Cynvenio, Menarini Silicon Biosystems, Adaptive Biotechnologies, Biocept, Angle plc, , etc. In 2021, the global top five players have a share of approximately % in terms of revenue.
In terms of the production, this report researches the Lung Cancer Liquid Biopsy Market capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of the sales, this report focuses on the sales of Lung Cancer Liquid Biopsy Market by region (region level and country level), by company, by Type and by Application from 2017 to 2022 and forecast to 2028.
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
COVID-19 Impact Analysis on Lung Cancer Liquid Biopsy Market Market
The report highlights the effects of the outbreak of COVID-19 on the development of the Lung Cancer Liquid Biopsy Market market across the globe. The authors studied the changes which affected the production/manufacturing, supply chain, consumption, and the demand/supply side. With the help of this report, the reader will get acquainted with the measures which helped the key industry players to get the Lung Cancer Liquid Biopsy Market market back to the pre-covid levels.
Global Lung Cancer Liquid Biopsy Market Market: Drivers and Restrains
The research report examines market trends, segments, applications, restraints and drivers which affect the global Lung Cancer Liquid Biopsy Market market. This report covers the global market for production volume, production by region, and pricing analysis for each type from 2018 to 2028. Factors influencing market development are important because they may be used to design diverse strategies for capturing the lucrative opportunities that exist in the continuously growing industry. In addition, market expert opinions have been incorporated for a better knowledge of the market.
Lung Cancer Liquid Biopsy market is segmented by players, region
(country), by Type and by Application. Players, stakeholders, and
other participants in the global Lung Cancer Liquid Biopsy market
will be able to gain the upper hand as they use the report as a
powerful resource. The segmental analysis focuses on revenue and
forecast by Type and by Application for the period 2017-2028.
Segment by Type
Exosomes and RNA
CTCs and ctDNA
Segment by Application
Menarini Silicon Biosystems
Rest of Europe
Rest of Asia
Rest of Latin America
Middle East & Africa
Rest of MEA